REFERENCES
1. Nedergaard M, Goldman SA. Glymphatic failure as a final common pathway to dementia. Science. 2020;370:50-6.
2. Ding XB, Wang XX, Xia DH, et al. Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson’s disease. Nat Med. 2021;27:411-8.
3. Kaur J, Fahmy LM, Davoodi-Bojd E, et al. Waste clearance in the brain. Front Neuroanat. 2021;15:665803.
4. Wei H, Jiang H, Zhou Y, Xiao X, Zhou C, Ji X. Vascular endothelial cells: a fundamental approach for brain waste clearance. Brain. 2023;146:1299-315.
5. Aldea R, Weller RO, Wilcock DM, Carare RO, Richardson G. Cerebrovascular smooth muscle cells as the drivers of intramural periarterial drainage of the brain. Front Aging Neurosci. 2019;11:1.
6. Khasawneh AH, Garling RJ, Harris CA. Cerebrospinal fluid circulation: what do we know and how do we know it? Brain Circ. 2018;4:14-8.
7. Saunders NR, Dziegielewska KM, Fame RM, Lehtinen MK, Liddelow SA. The choroid plexus: a missing link in our understanding of brain development and function. Physiol Rev. 2023;103:919-56.
8. Bohr T, Hjorth PG, Holst SC, et al. The glymphatic system: current understanding and modeling. iScience. 2022;25:104987.
9. Klostranec JM, Vucevic D, Bhatia KD, et al. Current concepts in intracranial interstitial fluid transport and the glymphatic system: Part I - anatomy and physiology. Radiology. 2021;301:502-14.
10. Xie L, Zhang Y, Hong H, et al. Higher intracranial arterial pulsatility is associated with presumed imaging markers of the glymphatic system: an explorative study. Neuroimage. 2024;288:120524.
11. Fultz NE, Bonmassar G, Setsompop K, et al. Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep. Science. 2019;366:628-31.
12. Zhou Y, Cai J, Zhang W, et al. Impairment of the glymphatic pathway and putative meningeal lymphatic vessels in the aging human. Ann Neurol. 2020;87:357-69.
13. Ringstad G, Vatnehol SAS, Eide PK. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain. 2017;140:2691-705.
14. Ringstad G, Eide PK. Cerebrospinal fluid tracer efflux to parasagittal dura in humans. Nat Commun. 2020;11:354.
15. van Osch MJP, Wåhlin A, Scheyhing P, et al. Human brain clearance imaging: pathways taken by magnetic resonance imaging contrast agents after administration in cerebrospinal fluid and blood. NMR Biomed. 2024;37:e5159.
16. Sun Y, Cao D, Pillai JJ, et al. Rapid imaging of intravenous gadolinium-based contrast agent (GBCA) entering ventricular cerebrospinal fluid (CSF) through the choroid plexus in healthy human subjects. Fluids Barriers CNS. 2024;21:72.
17. Naganawa S, Ito R, Kawai H, Taoka T, Yoshida T, Sone M. Confirmation of age-dependence in the leakage of contrast medium around the cortical veins into cerebrospinal fluid after intravenous administration of gadolinium-based contrast agent. Magn Reson Med Sci. 2020;19:375-81.
18. Yamamoto EA, Bagley JH, Geltzeiler M, et al. The perivascular space is a conduit for cerebrospinal fluid flow in humans: a proof-of-principle report. Proc Natl Acad Sci U S A. 2024;121:e2407246121.
19. Muccio M, Chu D, Minkoff L, et al. Upright versus supine MRI: effects of body position on craniocervical CSF flow. Fluids Barriers CNS. 2021;18:61.
20. Naganawa S, Taoka T, Ito R, Kawamura M. The glymphatic system in humans: investigations with magnetic resonance imaging. Invest Radiol. 2024;59:1-12.
21. Owashi KP, Liu P, Metanbou S, Capel C, Balédent O. Phase-contrast MRI analysis of cerebral blood and CSF flow dynamic interactions. Fluids Barriers CNS. 2024;21:88.
22. Vikner T, Johnson KM, Cadman RV, et al. CSF dynamics throughout the ventricular system using 4D flow MRI: associations to arterial pulsatility, ventricular volumes, and age. Fluids Barriers CNS. 2024;21:68.
23. Bito Y, Harada K, Ochi H, Kudo K. Low b-value diffusion tensor imaging for measuring pseudorandom flow of cerebrospinal fluid. Magn Reson Med. 2021;86:1369-82.
24. Wen Q, Tong Y, Zhou X, Dzemidzic M, Ho CY, Wu YC. Assessing pulsatile waveforms of paravascular cerebrospinal fluid dynamics within the glymphatic pathways using dynamic diffusion-weighted imaging (dDWI). Neuroimage. 2022;260:119464.
25. Han G, Jiao B, Zhang Y, et al. Arterial pulsation dependence of perivascular cerebrospinal fluid flow measured by dynamic diffusion tensor imaging in the human brain. Neuroimage. 2024;297:120653.
26. Chen Y, Hong H, Nazeri A, Markus HS, Luo X. Cerebrospinal fluid-based spatial statistics: towards quantitative analysis of cerebrospinal fluid pseudodiffusivity. Fluids Barriers CNS. 2024;21:59.
27. Taoka T, Masutani Y, Kawai H, et al. Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer’s disease cases. Jpn J Radiol. 2017;35:172-8.
28. Zhang W, Zhou Y, Wang J, et al. Glymphatic clearance function in patients with cerebral small vessel disease. Neuroimage. 2021;238:118257.
29. Delvenne A, Vandendriessche C, Gobom J, et al. Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies. Fluids Barriers CNS. 2024;21:58.
30. Li J, Hu Y, Xu Y, et al; Alzheimer’s Disease Neuroimaging Initiative. Associations between the choroid plexus and tau in Alzheimer’s disease using an active learning segmentation pipeline. Fluids Barriers CNS. 2024;21:56.
31. Zhen Z, Zhang R, Gui L, et al. Choroid plexus cysts on 7T MRI: relationship to aging and neurodegenerative diseases. Alzheimers Dement. 2025;21:e14484.
32. Wang S, Huang P, Zhang R, et al. Quantity and morphology of perivascular spaces: associations with vascular risk factors and cerebral small vessel disease. J Magn Reson Imaging. 2021;54:1326-36.
33. Huang P, Liu L, Zhang Y, et al; Alzheimer’s Disease Neuroimaging Initiative. Development and validation of a perivascular space segmentation method in multi-center datasets. Neuroimage. 2024;298:120803.
34. Albayram MS, Smith G, Tufan F, et al. Non-invasive MR imaging of human brain lymphatic networks with connections to cervical lymph nodes. Nat Commun. 2022;13:203.
35. Liu YJ, Lin SC, Liao CH, et al. MUSE and PROPELLER DWI for ADC in parasagittal dura: insights from high-resolution and reduced-distortion DWI. Sci Rep. 2025;15:7473.
36. Ran L, He Y, Zhu J, et al. Characterizing cerebrospinal fluid mobility using heavily T2-weighted 3D fast spin echo (FSE) imaging with improved multi-directional diffusion-sensitized driven-equilibrium (iMDDSDE) preparation. J Cereb Blood Flow Metab. 2024;44:105-17.
37. Wong SM, Backes WH, Drenthen GS, et al. Spectral diffusion analysis of intravoxel incoherent motion MRI in cerebral small vessel disease. J Magn Reson Imaging. 2020;51:1170-80.
38. Chen Y, Dai Z, Fan R, et al. Glymphatic system visualized by chemical-exchange-saturation-transfer magnetic resonance imaging. ACS Chem Neurosci. 2020;11:1978-84.
39. de Leon MJ, Li Y, Okamura N, et al. Cerebrospinal fluid clearance in Alzheimer disease measured with dynamic PET. J Nucl Med. 2017;58:1471-6.
40. Li Y, Rusinek H, Butler T, et al. Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease. Fluids Barriers CNS. 2022;19:21.
41. Jeong SH, Park CJ, Cha J, et al. Choroid plexus volume, amyloid burden, and cognition in the Alzheimer’s disease continuum. Aging Dis. 2024;16:552-64.
42. Jiang J, Zhuo Z, Wang A, et al. Choroid plexus volume as a novel candidate neuroimaging marker of the Alzheimer’s continuum. Alzheimers Res Ther. 2024;16:149.
43. Xu H, Lotfy P, Gelb S, et al. The choroid plexus synergizes with immune cells during neuroinflammation. Cell. 2024;187:4946-63.e17.
44. Banerjee G, Kim HJ, Fox Z, et al. MRI-visible perivascular space location is associated with Alzheimer’s disease independently of amyloid burden. Brain. 2017;140:1107-16.
45. Li Y, Zhu Z, Chen J, Zhang M, Yang Y, Huang P. Dilated perivascular space in the midbrain may reflect dopamine neuronal degeneration in Parkinson’s disease. Front Aging Neurosci. 2020;12:161.
46. Huang SY, Zhang YR, Guo Y, et al; Alzheimer’s Disease Neuroimaging Initiative. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer’s disease. Alzheimers Dement. 2024;20:3251-69.
47. Hong H, Hong L, Luo X, et al; Alzheimer’s Disease Neuroimaging Initiative (ADNI). The relationship between amyloid pathology, cerebral small vessel disease, glymphatic dysfunction, and cognition: a study based on Alzheimer’s disease continuum participants. Alzheimers Res Ther. 2024;16:43.
48. Zhou C, Jiang X, Guan X, et al. Glymphatic system dysfunction and risk of clinical milestones in patients with Parkinson disease. Eur J Neurol. 2024;31:e16521.
49. Jiang D, Liu L, Kong Y, et al; Frontotemporal Lobar Degeneration Neuroimaging Initiative. Regional glymphatic abnormality in behavioral variant frontotemporal dementia. Ann Neurol. 2023;94:442-56.
50. Thomas JH. Fluid dynamics of cerebrospinal fluid flow in perivascular spaces. J R Soc Interface. 2019;16:20190572.
51. Tadayon E, Pascual-Leone A, Press D, Santarnecchi E; Alzheimer’s Disease Neuroimaging Initiative. Choroid plexus volume is associated with levels of CSF proteins: relevance for Alzheimer’s and Parkinson’s disease. Neurobiol Aging. 2020;89:108-17.
